Formulation and Delivery
Bikash Chatterjee (he/him/his)
President and Chief Science Officer
Pharmatech Associates
Hayward, California
Stephanie Gaulding, CPGP, CQA (she/her/hers)
Managing Director
Pharmatech Associates
Hayward, California
Advanced drug discovery and design technologies, modeling and patient centricity are at the heart of new drug development programs, providing drug sponsors with a new arsenal of approaches to accelerate the development of new treatments. Patient-centric drug development is changing the philosophy of drug design; formulation by design is impacting the efficiency and effectiveness of technology transfer and scale up, and modeling can be successfully applied to reduce program risk and cycle time for critical steps in the development lifecycle.
These innovations are providing drug developers and manufacturers a way to shrink time to market, resulting in increased manufacturing effectiveness, lowering overall costs benefiting drug sponsors and patients alike.